Moreover, MK protein expression has been shown to be strongly correlated with poor prognosis in patients with neuroblastomas, astrocytomas, pancreatic head carcinomas, or gastrointestinal stromal tumors [74,75,76,77]. The gene discussed is MDK; the disease is neuroblastoma.